MODIFICATION OF THE BODY DISTRIBUTION OF POLY(METHYL METHACRYLATE) NANOPARTICLES IN RATS BY COATING WITH SURFACTANTS

被引:134
作者
TROSTER, SD
MULLER, U
KREUTER, J
机构
[1] UNIV FRANKFURT,INST PHARMACEUT TECHNOL,W-6000 FRANKFURT 1,GERMANY
[2] UNIV ZURICH,INST PHARMACOL,CH-8006 ZURICH,SWITZERLAND
关键词
Body distribution; Contact angle measurement; Drug targeting; Nanoparticle; Poly(methyl methacrylate); Surfactant coating;
D O I
10.1016/0378-5173(90)90047-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The body distribution of surfactant-coated and non-coated poly(methyl methacrylate) nanoparticles with a size of 131 ± 30 nm was determined in rats. A series of poloxamers/poloxamines, polysorbates as well as polyoxyethylene lauryl ether (Brij 35) were tested. No direct correlation was found between the body distribution pattern obtained and the contact angles of the surfactant solutions on PMMA. Nevertheless, all surfactants reduced the liver accumulation and increased the uptake in other parts of the body. Poloxamer 338 and poloxamine 908 were especially effective in reducing the liver uptake to a value of below 30% of the dose and maintaining significantly higher blood levels up to an increase factor of 103 for up to 6 h. The experiments also showed that spleen uptake is not a result of liver spillover because spleen concentrations reached values up to 50% of the total dose whereas at the same time only 25% was found in the liver. The uptake of nanoparticles in non-RES organs such as heart, GI tract, ovary, kidneys, muscles and brain was significantly increased with all surfactants. © 1990.
引用
收藏
页码:85 / 100
页数:16
相关论文
共 32 条
  • [1] ANDRADE JD, 1979, J POLYM SCI POL SYM, P313
  • [2] BLOOD-MATERIALS INTERACTIONS - THE MINIMUM INTERFACIAL FREE-ENERGY AND THE OPTIMUM POLAR APOLAR RATIO HYPOTHESES
    COLEMAN, DL
    GREGONIS, DE
    ANDRADE, JD
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1982, 16 (04): : 381 - 398
  • [3] Davis SS, 1986, SITE SPECIFIC DRUG D, P93
  • [4] BIODISTRIBUTION OF POLY(BUTYL 2-CYANOACRYLATE) NANOPARTICLES IN RABBITS
    DOUGLAS, SJ
    DAVIS, SS
    ILLUM, L
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 34 (1-2) : 145 - 152
  • [5] Gesler R M, 1973, Bull Parenter Drug Assoc, V27, P101
  • [6] PHARMACOKINETICS AND DISTRIBUTION OF A BIODEGRADABLE DRUG-CARRIER
    GRISLAIN, L
    COUVREUR, P
    LENAERTS, V
    ROLAND, M
    DEPREZDECAMPENEERE, D
    SPEISER, P
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 15 (03) : 335 - 345
  • [7] HOGT AH, 1985, J COLLOID INTERF SCI, V106, P289, DOI 10.1016/S0021-9797(85)80002-3
  • [8] THE ORGAN UPTAKE OF INTRAVENOUSLY ADMINISTERED COLLOIDAL PARTICLES CAN BE ALTERED USING A NON-IONIC SURFACTANT (POLOXAMER-338)
    ILLUM, L
    DAVIS, SS
    [J]. FEBS LETTERS, 1984, 167 (01) : 79 - 82
  • [9] ILLUM L, 1982, INT J PHARM, V12, P135
  • [10] ILLUM L, 1986, INT J PHARM, V29, P53